Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2007-4-26
pubmed:abstractText
The topical calcineurin inhibitors pimecrolimus and tacrolimus have been demonstrated to be an effective new anti-inflammatory therapy. The only clinically relevant side-effect reported is transient application site burning and stinging itch at the beginning of topical therapy.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
0007-0963
pubmed:author
pubmed:issnType
Print
pubmed:volume
156
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1020-6
pubmed:meshHeading
pubmed:year
2007
pubmed:articleTitle
Topical pimecrolimus and tacrolimus transiently induce neuropeptide release and mast cell degranulation in murine skin.
pubmed:affiliation
Department of Dermatology and Boltzmann Institute for Immuno- and Cell Biology of the Skin, University of Münster, Von-Esmarch-Strasse 58, Münster, Germany. sonja.staender@uni-muenster.de
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't